- 公司资讯
- finviz | 2019年08月29日 04:05ImmunoCellular Therapeutics Announces Completion of Asset Purchase Transaction with Private Biotechnology Company
- finviz | 2019年08月09日 18:00ImmunoCellular Therapeutics: Notice of Proposed Settlement of Derivative Action
- finviz | 2019年07月17日 04:05ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company
- finviz | 2018年10月17日 18:00ImmunoCellular Announces Receipt of Notice of Noncompliance with The NYSE American Continued Listing Standards
- finviz | 2018年10月16日 04:05ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants
- finviz | 2018年09月05日 20:15New Research Coverage Highlights K12, ImmunoCellular Therapeutics, The First of Long Island, Blue Bird, The Providence Service, and German American Consolidated Revenues, Company Growth, and Expectations for 2018
- finviz | 2018年08月16日 20:10Research Report Identifies Gastar Exploration, Monroe Capital, SandRidge Energy, ImmunoCellular Therapeutics, Inseego, and Digital Turbine with Renewed Outlook Fundamental Analysis, Calculating Forward Movement
- finviz | 2018年08月14日 04:05ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results
- finviz | 2018年07月19日 18:00ImmunoCellular Therapeutics Announces Agreement on Terms of Settlement of Federal Class Action Shareholder Lawsuit
- finviz | 2018年06月22日 19:30Free Technical Research on ImmunoGen and Three More Biotech Equities
- finviz | 2018年05月15日 04:05ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results
- finviz | 2018年05月11日 19:05Complimentary Stock Performance Review on La Jolla Pharma and Three Additional Biotech Industry Stocks
- finviz | 2018年05月08日 20:00Analysis: Positioning to Benefit within DDR, Diamond Offshore Drilling, Energen, ImmunoCellular Therapeutics, Juniper Networks, and ServiceNow Research Highlights Growth, Revenue, and Consolidated Results
- finviz | 2018年04月16日 19:50Blog Exposure - ImmunoCellular Therapeutics Reported Achievement of Next Key Milestone in Validating Stem-to-T-Cell Program
- finviz | 2018年04月12日 18:00ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program
- finviz | 2018年03月26日 18:00ImmunoCellular Therapeutics Receives Audit Opinion with Going Concern Explanation
首页
上页
下页